Loading clinical trials...
Loading clinical trials...
An Open Label Trial of Telbivudine (LdT) in Adults With Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies
Conditions
Interventions
Telbivudine (LdT)
Locations
39
United States
Novartis Investigational Site
Phoenix, Arizona, United States
Novartis Investigational Site
Los Angeles, California, United States
Novartis Investigational Site
Los Angeles, California, United States
Novartis Investigational Site
Pasadena, California, United States
Novartis Investigational Site
Sacramento, California, United States
Novartis Investigational Site
San Diego, California, United States
Start Date
March 1, 2005
Primary Completion Date
November 1, 2009
Completion Date
November 1, 2009
Last Updated
August 21, 2020
NCT07417553
NCT02932150
NCT06671093
NCT05853718
NCT06885710
NCT06906016
Lead Sponsor
Novartis Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions